These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8177138)

  • 1. Captopril for diabetic nephropathy.
    Med Lett Drugs Ther; 1994 May; 36(923):46-7. PubMed ID: 8177138
    [No Abstract]   [Full Text] [Related]  

  • 2. Captopril in diabetic nephropathy.
    Fong M; Hart LL
    DICP; 1990 Mar; 24(3):260-1. PubMed ID: 2180219
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
    Parving HH
    N Engl J Med; 1994 Mar; 330(13):937-8. PubMed ID: 8114875
    [No Abstract]   [Full Text] [Related]  

  • 4. Slowing the progression of diabetic nephropathy.
    Remuzzi G; Ruggenenti P
    N Engl J Med; 1993 Nov; 329(20):1496-7. PubMed ID: 8413463
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
    Fournier A; Lalau JD
    N Engl J Med; 1994 Mar; 330(13):937; author reply 938. PubMed ID: 8114873
    [No Abstract]   [Full Text] [Related]  

  • 6. Captopril and diabetic nephropathy.
    Lewis EJ
    JAMA; 1995 Jun; 273(23):1831. PubMed ID: 7776492
    [No Abstract]   [Full Text] [Related]  

  • 7. Captopril, blood pressure, and diabetic nephropathy.
    Sawicki PT; Mühlhauser I; Berger M
    JAMA; 1994 Oct; 272(13):1005. PubMed ID: 8089882
    [No Abstract]   [Full Text] [Related]  

  • 8. Changing the course of diabetic nephropathy: angiotensin-converting enzyme inhibition in type I diabetic renal disease.
    Pohl MA
    Cleve Clin J Med; 1994; 61(1):38-42. PubMed ID: 8124846
    [No Abstract]   [Full Text] [Related]  

  • 9. [Economic evaluation of the contribution of captopril in the treatment of diabetic nephropathy:a cost-benefit approach].
    Le Pen C; Petitjean P; Lévy P; Hannedouche T
    Nephrologie; 1996; 17(6):321-6. PubMed ID: 8975150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetic Nephropathy. Captopril can improve survival in hypertensive diabetics. Proceedings of a symposium at the IFECC III. Monte Carlo, January 1994].
    Internist (Berl); 1994 Apr; 35(4 Suppl):1-4. PubMed ID: 8188458
    [No Abstract]   [Full Text] [Related]  

  • 11. Longitudinal evaluation of renal function in non-insulin-dependent diabetic patients with early nephropathy: effects of angiotensin-converting enzyme inhibition.
    Vora JP; Leese GP; Peters JR; Owens DR
    J Diabetes Complications; 1996; 10(2):88-93. PubMed ID: 8777336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensives retarding progression of diabetic nephropathy.
    Hardy KJ
    Diabetologia; 1995 Jan; 38(1):123-4. PubMed ID: 7744219
    [No Abstract]   [Full Text] [Related]  

  • 13. [Captopril--new additional applications].
    Shachar A; Shoenfeld Y
    Harefuah; 1990 Nov; 119(9):280-2. PubMed ID: 2258119
    [No Abstract]   [Full Text] [Related]  

  • 14. ACE inhibition and diabetic nephropathy.
    BMJ; 1991 Nov; 303(6814):1400-1. PubMed ID: 1810297
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.
    Lopez A; Marantz PR
    N Engl J Med; 1994 Mar; 330(13):937; author reply 938. PubMed ID: 8114874
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of captopril on diabetic proteinuria.
    N Engl J Med; 1986 Aug; 315(8):515-6. PubMed ID: 3526154
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of captopril and prazosin on renal function in diabetes.
    Omar MA; Motala AA; Seedat MA; Randeree HA
    S Afr Med J; 1993 May; 83(5):365. PubMed ID: 8211440
    [No Abstract]   [Full Text] [Related]  

  • 18. [The significance of deletion polymorphism in the ACE gene for progression of diabetic nephropathies treated with ACE inhibitors].
    Tarnow L; Parving HH; Jacobsen P; Rossing P; Lecerf L; Poirier O; Cambien F
    Ugeskr Laeger; 1998 Aug; 160(34):4886-9. PubMed ID: 9741257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy.
    Jimenez J; Safranek S; Viera AJ
    Am Fam Physician; 2007 Aug; 76(3):423-4. PubMed ID: 17708144
    [No Abstract]   [Full Text] [Related]  

  • 20. [Angiotensin-converting enzyme inhibition and progressing chronic nephropathy].
    Kamper AL; Strandgaard S
    Ugeskr Laeger; 1997 Nov; 159(48):7121-3. PubMed ID: 9417716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.